Causes of Phencyclidine- Related Deaths

References

• Domino E. F., Luby E. D. Abnormal Mental States Induced by PCP as a Model for Schizophrenia. Psychopathology and Psychopharmacology, J. O. Cole, A. M. Freedman, A. J. Friedhoff. John Hopkins Univ. Press, Baltimore, Md. 1972; 37–50
   Google Scholar
• Domino E. F. Neurobiology of PCP (Sernyl), a drug with an unusual spectrum of pharmacological activity. Int. Rev. Neurobiol. 1964; 6: 303
   PubMed Web of Science ®Google Scholar
• James S. H., Schnoll S. H. Phencyclidine: tissue distribution in the rat. Clin. Toxicol. 1976; 9(4)573
   PubMed Web of Science ®Google Scholar
• Greifenstein F. E., Yoshitake J., DeVault M., Gajewski J. E. A study of 1‐aryl cyclo hexyl amine for anesthesia. Anesth. and Analg., Current Res. 1958; 37(5)283
   PubMedGoogle Scholar
• Rodin E. A., Luby E. D., Meyer J. S. Electroencephalograph‐ic findings associated with Sernyl infusion. EEG Clin. Neuro‐physiol. 1958; 11: 796
   Web of Science ®Google Scholar
• Chen G., Ensor C. R., Bohner B. The neuropharmacology of 2‐(O‐chlorophenyl)‐2‐methylamino‐cyclohexanone hydrochloride. J. Pharmacol. Exp. Therap. 1966; 152: 332
   PubMed Web of Science ®Google Scholar
• Munch J. C. Phencyclidine: pharmacology and toxicology. Bulletin on Narcotics October‐December, 1974; 26(4)
   PubMedGoogle Scholar
• Chen G. Sympathomimetic anesthetics. Can. Anesth. Soc. J. March, 1973; 20(2)
   PubMedGoogle Scholar
• McCarthy D. A., Chen G., Kaump D. H., Ensor C. General anesthetic and other pharmacological properties of 2‐(O‐chloro‐phenyl)‐2‐methylaminocyclohexanone HCl (CI‐581). J. New Drugs Jan‐Feb, 1965; 21–33
   PubMedGoogle Scholar
• Chen G. M., Weston J. K. The analgesic and anesthetic effect of 1‐(1‐phenylcyclohexyl)piperidine HCl on the monkey. Anesth. Analg., Current Res. 1960; 39(2)132
   PubMedGoogle Scholar
• Chen G., Ensor C. R., Russell D., Bohner B. The pharmacology of 1–1(phenylcyclohexyl)piperidine HCl. J. Pharmacol. Exp. Therap. 1959; 127: 241
   PubMed Web of Science ®Google Scholar
• Chen G. Evaluation of phencyclidine‐type cataleptic activity. Arch. Int. Pharmacodyn. 1965; 157: 193
   PubMedGoogle Scholar
• Domino E. F., Chodoff P., Corssen G. Pharmacologic effects of CI‐581, a new dissociative anesthetic in man. Clin. Pharmacol. Therap. 1965; 6(3)279
   PubMed Web of Science ®Google Scholar
• Corssen G., Domino E. F. Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI‐581. Anesthesia Analgesia, Current Res. 1966; 45: 29
   PubMed Web of Science ®Google Scholar
• Ferrer A. T., Breckner V. L., Dymond A., Cozen H., Crandall P. Ketamine induced electroconvulsive phenomena in the human limbic and thalamic regions. Anesthesiology 1973; 38(4)333
   PubMed Web of Science ®Google Scholar
• Winters W. D., Ferrer A. T., Guzman‐Flores C., Alcaraz M. The cataleptic state induced by ketamine: a review of the neuropharmacology of anesthesia. Neuropharmacology 1972; 11: 303
   PubMed Web of Science ®Google Scholar
• Balster R. L., Chait L. D. The behavioral pharmacology of phencyclidine. Clin. Toxicol. 1976; 9(4)513
   PubMed Web of Science ®Google Scholar
• Balster R. L., personal communication
   Google Scholar
• Collins V. J., Gorospe C. A., Rovenstine E. A. Intravenous nonbarbiturate, nonnarcotic analgesics: preliminary studies. 1. cyclohexylamines. Anesthesia Analgesia, Current Res. 1960; 39: 302
   PubMedGoogle Scholar
• Luisada P., Reddick C. An Epidemic of Drug‐Induced Schizophrenia. presented at the 128th Annual Meeting of the American Psychiatric Association, Anaheim, California, May, 5–91975
   Google Scholar
• Luby E. D., Cohen B. D., Rosenbaum G., Gottlieb J. S., Kelly R. Study of a new schizophrenomimetic drug—Sernyl. Arch. Neurol. Psychiat. 1959; 81: 363
   PubMedGoogle Scholar
• Rosenbaum G., Cohen B. D., Luby E. D., Gottlieb J. S., Yelen D. Comparison of Sernyl with other drugs. Arch. Gen. Psychiat. 1959; 1: 113
   Google Scholar
• Davies B. M. “Phencyclidine: Its Use in Psychiatry”, in Hallucinogenic Drugs and Their Psychotherapeutic Use. Proceedings of the Royal Medico‐Psychol. Association in London. February, 1971, R. Crocket, R. A. Sandison, A. Walk. 42–47
   Google Scholar
• Davies B. M., Beech H. R. The effect of 1‐arylcyclohexyl‐amine (Sernyl) on twelve normal volunteers. J. Mental Sci. 1960; 106: 912
   PubMed Web of Science ®Google Scholar
• Morgenstein F. S., Beech H. R., Davies B. M. An investigation of drug induced sensory disturbances. Psychopharmacology 1962; 3: 193
   PubMedGoogle Scholar
• Beech H. R., Davies B. M., Morgenstern F. S. Preliminary investigations of the effects of Sernyl upon cognitive and sensory processes. J. Mental Sci., May 1961; 509
   Google Scholar
• Davies B. M. Oral Sernyl in obsessive states. J. Mental Sci. January, 1961; 109
   PubMed Web of Science ®Google Scholar
• Ober R. E., Gwynn G. W., McCarthy D. A., Glazko A. J. Metabolism of 1‐(1‐phenylcyclohexyl)piperidine (Semyl). Federation Proc. 1963; 22(2)539
   Google Scholar
• Glazko A. J. Identification of Chloramphenicol Metabolites and Some Factors Affecting Metabolic Disposition. Antimicrobial Agents and Chemotherapy‐1966. American Society for Microbiology. 1967; 660–661
   Google Scholar
• Lin D. C., Fentiman A. F., Foltz R. L., Forney R. D., Sunshine I. Quantification of phencyclidine in body fluids by gas chromatography chemical ionization mass spectrometry and identification of two metabolites. Biomedical Mass Spectrometry 1975; 2: 206
   Google Scholar
• McCarthy D. A., Potter D. The metabolites of phencyclidine. Pharmacologist 1963; 5(2)265
   Google Scholar
• James S. H., Schnoll S. H. Phencyclidine: tissue distribution in the rat. Clin. Toxicol. 1976; 9(4)573
   PubMed Web of Science ®Google Scholar
• Done A. K., Aronow R., Miceli J. N., Lin D. C. Pharmacokinetic Observations in the Treatment of Phencyclidine Poisoning. A Preliminary Report. Management of the Poisoned Patient, B. H. Rumack, A. R. Temple. Science Press, Princeton 1977; 79–102
   Google Scholar
• Lundberg G. D., Gupta R. C., Montgomery S. H. Phencyclidine: patterns seen in street drug analysis. Clin. Toxicol. 1976; 9(4)503
   PubMed Web of Science ®Google Scholar
• Radcliff B., personal communication.
   Google Scholar
• Perry D. C. PCP revisited. Pharm Chem Newsletter 1975; 4(9)1
   Google Scholar
• Burns R. S., Lerner S. E., Corrado R., James S. H., Schnoll S. H. Phencyclidine‐states of acute intoxication and fatalities. Western J. of Med. 1975; 123(5)345
   PubMedGoogle Scholar
• MacLean D., personal communication
   Google Scholar
• Shulgin A. T., MacLean D. Illicit synthesis of phencyclidine (PCP) and several of its analogs. Clin. Toxicol. 1976; 9(4)553
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration. June 5, 1975, personal communication
   Google Scholar
• Burns R. S., Lerner S. E. The crystal people: chronic daily users of phencyclidine, in preparation
   Google Scholar
• Burns R. S., Lerner S. E. “Street PCP Use: Clinical Studies of Acute and Chronic Intoxication.”. Paper presented to the California Association of Toxicologists, San Jose, California, August, 21975
   Google Scholar
• Burns R. S., Lerner S. E. Management and Treatment of Acute Phencyclidine Intoxication. Acute Drug Abuse Emergencies, C. Peter Bourne. Academic, New York 1976; 297–305
   Google Scholar
• Burns R. S., Lerner S. E. Perspectives: acute phencyclidine intoxication. Clin. Toxicol. 1976; 9(4)477
   PubMed Web of Science ®Google Scholar
• Marshman J. A., Ramsay M. P., Sellers E. M. Quantification of phencyclidine in biological fluids and application to human overdose. Toxicol. Appl. Pharmacol. 1976; 35: 129
   PubMed Web of Science ®Google Scholar
• Stockard J. J., Werner S. S., Aalbers J. A., Chiappa K. H. Electroencephalographic findings in phencyclidine intoxication. Arch. Neurol. 1976; 33: 200
   PubMed Web of Science ®Google Scholar
• Kessler G. F., Demers L. M., Berlin C., Brennan R. W. Phencyclidine and fatal status epilepticus. New Engl. J. Med. 1974; 291(18)979
   PubMed Web of Science ®Google Scholar
• Reynolds P. C. Clinical and forensic experiences with phencyclidine. Clin. Toxicol. 1976; 9(4)547
   PubMed Web of Science ®Google Scholar
• Liden C. B., Lovejoy F. H., Costello C. E. Phencyclidine. JAMA 1975; 234(5)513
   PubMed Web of Science ®Google Scholar
• Fauman B., Aldinger G., Fauman M., Rosen P. Psychiatric sequelae of phencyclidine abuse. Clin. Toxicol. 1976; 9(4)529
   PubMed Web of Science ®Google Scholar
• Eastman J. W., Cohen S. N. Hypertensive crisis and death associated with phencyclidine poisoning. JAMA 1975; 231(12)1270
   PubMed Web of Science ®Google Scholar
• Dandavino R., Friborg J., Beaudry C., Laplante L. Un cas d'intoxication aiguë a la phencyclidine anec atteinte musculaire importante et insuffisance rénale aiguë. L'Union Médicale Du Canada 1975; 104: 57
   PubMedGoogle Scholar
• Baselt R. C., Wright J. A., Cravey R. H. Therapeutic and toxic concentrations of more than 100 toxicologically significant drugs in blood, plasma, or serum: a tabulation. Clin. Chem. 1975; 21: 44
   PubMed Web of Science ®Google Scholar
• Kazyak Leo, personal communication
   Google Scholar
• Burns R. S., Lerner S. E. Perspectives: acute phencyclidine intoxication (revised). Problems of Drug Dependence. Committee of Problems of Drug Dependence, National Academy of Sciences. 1976; 552–574
   Google Scholar